Search for Clinical Trial Results
Oligodendroglioma - 253 Studies Found
Status | Study |
Completed |
Study Name: Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma Condition: Brain and Central Nervous System Tumors Date: 1999-11-01 Interventions:
|
Active, not recruiting |
Study Name: Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma Condition:
Date: 2007-12-22 Interventions: Drug: temozolomide followed by high dose busulfan and thiotepa Temozolomide 200mg/m2 PO Days 1-5 recycle |
Completed |
Study Name: Temozolomide in Treating Patients With Anaplastic Oligodendroglioma Condition: Brain and Central Nervous System Tumors Date: 1999-11-01 Interventions: Drug: temozolomide |
Completed |
Study Name: Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma Condition: Brain and Central Nervous System Tumors Date: 1999-11-01 Interventions:
|
Active, not recruiting |
Study Name: Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma Condition:
Date: 2006-11-16 Interventions: Drug: temozolomide Schedule of Temozolomide administration: Temozolomide, 150 mg/m2/d x days 1-7 and 15- |
Completed |
Study Name: Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma Condition: Brain and Central Nervous System Tumors Date: 1999-11-01 Interventions:
|
Active, not recruiting |
Study Name: Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas Condition: Brain and Central Nervous System Tumors Date: 2002-04-09 Interventions:
|
Completed |
Study Name: Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma Condition: Brain and Central Nervous System Tumors Date: 1999-11-01 Interventions:
|
Recruiting |
Study Name: Multicenter Safety Trial Assessing an Innovative Tumor Molecular and Cellular Print Medical Device in Glioma Condition: Glioma : Oligodendroglioma or Astrocytoma Date: 2013-10-10 Interventions: Device: Molecular and cellular tumor print Medical Device (ProTool) Proteomic, genomic and cellular cult |
Active, not recruiting |
Study Name: Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor Condition:
Interventions: |